THE TORO COMPANY financials

TTC CIK 0000737758

Source: EDGAR filings · Built 2026-06-02T04:14:07Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 578.30M 466.40M 157.30M 153.70M 451.50M 461.31M
EBITDA 552.80M 661.50M 549.90M 684.50M 617.60M 521.97M
Working Capital 792.70M 788.90M 850.20M 611.80M 552.17M 571.85M
Net Debt 700.10M 841.70M 970.00M 881.95M 355.68M 393.31M
Gross Margin 33.36% 33.80% 34.65% 33.33% 33.80% 35.21%
Operating Margin 9.09% 11.63% 9.46% 12.75% 13.09% 12.62%
Net Margin 7.01% 9.14% 7.24% 9.82% 10.35% 9.76%
Return on Equity (ROE) 21.75% 26.99% 21.82% 32.80% 35.61% 29.57%
Return on Assets (ROA) 9.19% 11.69% 9.05% 12.47% 13.96% 11.56%
Current Ratio 1.87× 1.81× 1.90× 1.58× 1.59× 1.67×
Debt-to-Equity 0.72× 0.67× 0.77× 0.79× 0.66× 0.78×
Effective Tax Rate 16.29% 18.31% 17.68% 19.76% 17.99% 19.01%
Cash Conversion Ratio 2.09× 1.36× 0.93× 0.67× 1.36× 1.64×
Accruals Ratio -0.10× -0.04× 0.01× 0.04× -0.05× -0.07×
SBC % of Revenue 0.42% 0.50% 0.43% 0.49% 0.55% 0.46%
CapEx Coverage 7.91× 5.51× 2.05× 2.07× 5.34× 6.91×
Free Cash Flow Per Share $5.79 $4.47 $1.49 $1.46 $4.16 $4.25

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 23.57× 20.07× 25.83× 25.10× 25.26× 27.10×
P/FCF 12.90× 18.02× 54.12× 72.44× 22.94× 19.34×
FCF Yield 7.75% 5.55% 1.85% 1.38% 4.36% 5.17%
EV / EBITDA 14.50× 13.62× 17.03× 17.30× 16.84× 17.68×
P/S 1.62× 1.78× 1.84× 2.43× 2.54× 2.61×
P/B 5.03× 5.26× 5.56× 8.11× 8.73× 7.92×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 4.51B 4.58B 4.55B 4.51B 3.96B 3.38B
Cost of Goods and Services Sold 3.01B 3.03B 2.98B 3.01B 2.62B 2.19B
Gross Profit 1.50B 1.55B 1.58B 1.50B 1.34B 1.19B
Research and Development Expense 162.30M 173.10M 173.90M 155.60M 141.00M 124.10M
Selling, General and Administrative Expense 1.01B 1.02B 995.60M 928.90M 820.20M 763.42M
Operating Income (Loss) 409.90M 533.30M 430.70M 575.70M 518.30M 426.36M
Income Tax Expense (Benefit) 61.50M 93.90M 70.80M 109.20M 89.90M 77.37M
Net Income (Loss) Attributable to Parent 316.10M 418.90M 329.70M 443.30M 409.90M 329.70M
Earnings Per Share, Basic $3.18 $4.04 $3.16 $4.23 $3.82 $3.06
Weighted Average Number of Shares Outstanding, Basic 99.50M 103.80M 104.40M 104.80M 107.30M 107.66M
Earnings Per Share, Diluted $3.17 $4.01 $3.13 $4.20 $3.78 $3.03
Weighted Average Number of Shares Outstanding, Diluted 99.80M 104.40M 105.30M 105.60M 108.50M 108.66M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Assets, Current 1.71B 1.76B 1.80B 1.68B 1.49B 1.43B
Assets 3.44B 3.58B 3.64B 3.56B 2.94B 2.85B
Long-term Debt 921.50M 921.80M 1.03B 990.80M 691.24M 791.12M
Liabilities, Current 912.40M 976.00M 948.60M 1.06B 937.02M 855.80M
Long-term Debt, Excluding Current Maturities 921.50M 911.80M 1.03B 990.80M 691.24M 691.25M
Stockholders' Equity Attributable to Parent 1.45B 1.55B 1.51B 1.35B 1.15B 1.11B
Common Stock, Shares, Outstanding 97.89M 101.47M 103.84M 103.97M 105.21M 107.58M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 662.00M 569.90M 306.80M 297.20M 555.50M 539.37M
Payments to Acquire Property, Plant, and Equipment 83.70M 103.50M 149.50M 143.50M 104.00M 78.07M
Net Cash Provided by (Used in) Investing Activities -77.40M -59.70M -157.70M -548.30M -128.50M -216.08M
Payments for Repurchase of Common Stock 290.00M 245.50M 60.00M 140.00M 302.30M 0
Net Cash Provided by (Used in) Financing Activities -446.10M -505.10M -147.50M 42.20M -503.70M 2.35M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (TTC CIK 0000737758), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

DX

DYNEX CAPITAL, INC.

NHC

NATIONAL HEALTHCARE CORP

VTEX

VTEX